(Q41871561)

13 October 2017

title

Sustained reflow in dogs with coronary thrombosis with K2P, a novel mutant of tissue-plasminogen activator (English)

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90164-I

14 October 2022

1 reference

Cardiology and cardiovascular medicine

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90164-I

14 October 2022

author name string

F. A. Nicolini

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1607530

14 October 2022

W. W. Nichols

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1607530

14 October 2022

J. L. Mehta

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1607530

14 October 2022

T. G. Saldeen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1607530

14 October 2022

R. Schofield

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1607530

14 October 2022

M. Ross

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1607530

14 October 2022

D. W. Player

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1607530

14 October 2022

G. B. Pohl

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1607530

14 October 2022

C. Mattsson

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1607530

14 October 2022

language of work or name

English

0 references

publication date

1 July 1992

1 reference

full work available at URL

13 October 2017

https://api.elsevier.com/content/article/PII:073510979290164I?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90164-I

https://api.elsevier.com/content/article/PII:073510979290164I?httpAccept=text/plain

14 October 2022

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90164-I

Journal of the American College of Cardiology

14 October 2022

published in

1 reference

13 October 2017

volume

20

1 reference

13 October 2017

issue

1

1 reference

13 October 2017

page(s)

228-235

1 reference

Prostacyclin analogue iloprost decreases thrombolytic potential of tissue-type plasminogen activator in canine coronary thrombosis

13 October 2017

cites work

4

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90164-I

Concurrent nitroglycerin administration decreases thrombolytic potential of tissue-type plasminogen activator

14 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90164-I

Epoprostenol (prostacyclin,PGI2) increases apparent liver blood flow in man

14 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90164-I

Pharmacokinetics and Coronary Thrombolytic Properties of Two Human Tissue-Type Plasminogen Activator Variants Lacking the Finger-Like, Growth Factor-Like, and First Kringle Domains (Amino Acids 6–173) in a Canine Model

14 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90164-I

Electrical induction of coronary artery thrombosis in the ambulatory canine: a model for in vivo evaluation of anti-thrombotic agents

14 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90164-I

Coronary vascular occlusion mediated via thromboxane A2-prostaglandin endoperoxide receptor activation in vivo

14 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90164-I

Regional myocardial function during acute coronary artery occlusion and its modification by pharmacologic agents in the dog

14 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90164-I

Synchronized pulsed Doppler blood flow and ultrasonic dimension measurement in conscious dogs

14 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90164-I

"Fibrinolytic potential": the response to a 5 minute venous occlusion test

14 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90164-I

Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion

14 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90164-I

The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.

14 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90164-I

Tissue plasminogen activator: Toronto (TPAT) placebo-controlled randomized trial in acute myocardial infarction.

14 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90164-I

A comparison between heparin and low-dose aspirin as adjunctive therapy with tissue plasminogen activator for acute myocardial infarction. Heparin-Aspirin Reperfusion Trial (HART) Investigators

14 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90164-I

Acute coronary reocclusion after thrombolysis with recombinant human tissue-type plasminogen activator: prevention by a maintenance infusion

14 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90164-I

Blood flow reductions in stenosed canine coronary arteries: vasospasm or platelet aggregation?

14 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90164-I

Streptokinase inhibits acute platelet thrombus formation in stenosed dog coronary arteries

14 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90164-I

Iloprost and tissue-type plasminogen activator differently affect platelet aggregation in platelet-rich plasma and in whole blood

14 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90164-I

Thromboxane and prostacyclin release from ischaemic myocardium in relation to arrhythmias

14 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90164-I

Importance of continued activation of thrombin reflected by fibrinopeptide A to the efficacy of thrombolysis

14 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90164-I

Effects of thrombin inhibition on the development of acute platelet-thrombus deposition during angioplasty in pigs. Heparin versus recombinant hirudin, a specific thrombin inhibitor

14 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90164-I

Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors

14 October 2022

31

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90164-I

Interactions of tissue-type plasminogen activator with plasma inhibitors and their pharmacologic implications

14 October 2022

32

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90164-I

Paradoxic elevation of fibrinopeptide A after streptokinase: evidence for continued thrombosis despite intense fibrinolysis

14 October 2022

33

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90164-I

14 October 2022

Identifiers

1 reference

13 October 2017

1 reference